Identification of low micromolar SARS-CoV-2 Mpro inhibitors from hits identified by in silico screens
Rossetti, G. G.; Ossorio, M.; Barriot, S.; Tropia, L.; Dionellis, V. S.; Gorgulla, C.; Arthanari, H.; Mohr, P.; Gamboni, R.; Halazonetis, T. D.
Show abstract
Mpro, also known as 3CLpro, is the main protease of the SARS-CoV-2 coronavirus and, as such, is essential for the viral life cycle. Two studies have each screened and ranked in silico more than one billion chemical compounds in an effort to identify putative inhibitors of Mpro. More than five hundred of the seven thousand top-ranking hits were synthesized by an external supplier and examined with respect to their activity in two biochemical assays: a protease activity assay and a thermal shift assay. Two clusters of chemical compounds with Mpro inhibitory activity were identified. An additional five hundred molecules, analogues of the compounds in the two clusters described above, were also synthesized and characterized in vitro. The study of the analogues revealed that the compounds of the first cluster acted by denaturing Mpro and might denature other proteins as well. In contrast, the compounds of the second cluster targeted Mpro with much greater specificity and enhanced its melting temperature, consistent with the formation of stable Mpro-inhibitor complexes. The most active compounds of the second cluster exhibited IC50 values between 4 and 7 M and their chemical structure suggests that they could serve as leads for the development of potent Mpro inhibitors.
Matching journals
The top 11 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Identifying SARS-CoV-2 Antiviral Compounds by Screening for Small Molecule Inhibitors of Nsp3 Papain-like Protease 95%
- Development of novel anti-malarial from structurally diverse library of molecules, targeting plant-like Calcium Dependent Protein Kinase 1, a multistage growth regulator of P. falciparum 94%
- Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach 93%
Similar papers in this journal
- Development of pyrazolopyrimidine based macrocyclic kinase inhibitors targeting AAK1 96%
- Optimization of pyrazolopyrimidines lead to the identification of a highly selective casein kinase 2 inhibitor 95%
- Modulation of endogenous opioid signaling by inhibitors of puromycin sensitive aminopeptidase 95%
Similar papers in this journal
- Drug Repurposing for the SARS-CoV-2 Papain-Like Protease 96%
- Structure-Based Virtual Screening Identifies TREM2-Targeted Small Molecules that Enhance Microglial Phagocytosis 95%
- MPI8 is Potent Against SARS-CoV-2 by Inhibiting Dually and Selectively the SARS-CoV-2 Main Protease and the Host Cathepsin L 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.